Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by FactFinder1994on Apr 06, 2021 10:13am
87 Views
Post# 32940977

RE:RE:Semi-public Company

RE:RE:Semi-public CompanyStakeholders here can walk and chew gum.  
Its a conscious choice in keeping this company well under the radar.  
If the story is shared the value of the company moves up by multiples of current level.  
On Thursday's FDA-EUA submission the stock traded lass than $50K all totalled for the day.
Think about that....
On March 24, 2020 when SQI announced they would be working on this same (1 hour triage test) the stock traded in excess of $2,250,000 that day.
Think about that too... 
Just the opportunity associated with this single product is hundreds of millions of dollars annually.  
The equally troubling issue is that SQI represents a bright beacon of help for emergency room doctors, yet they too remain in the dark.  There are many lives at stake, and near silence is not in keeping with an admirable value set.
Its simple and reasonable.  Share the Story now, or investigate those who have been controlling/manipulating the value of SQI.          
 
<< Previous
Bullboard Posts
Next >>